Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

218 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The circular RNome of primary breast cancer.
Smid M, Wilting SM, Uhr K, Rodríguez-González FG, de Weerd V, Prager-Van der Smissen WJC, van der Vlugt-Daane M, van Galen A, Nik-Zainal S, Butler A, Martin S, Davies HR, Staaf J, van de Vijver MJ, Richardson AL, MacGrogan G, Salgado R, van den Eynden GGGM, Purdie CA, Thompson AM, Caldas C, Span PN, Sweep FCGJ, Simpson PT, Lakhani SR, Van Laere S, Desmedt C, Paradiso A, Eyfjord J, Broeks A, Vincent-Salomon A, Futreal AP, Knappskog S, King T, Viari A, Børresen-Dale AL, Stunnenberg HG, Stratton M, Foekens JA, Sieuwerts AM, Martens JWM. Smid M, et al. Among authors: macgrogan g. Genome Res. 2019 Mar;29(3):356-366. doi: 10.1101/gr.238121.118. Epub 2019 Jan 28. Genome Res. 2019. PMID: 30692147 Free PMC article.
Genomic characterisation of hormone receptor-positive breast cancer arising in very young women.
Luen SJ, Viale G, Nik-Zainal S, Savas P, Kammler R, Dell'Orto P, Biasi O, Degasperi A, Brown LC, Láng I, MacGrogan G, Tondini C, Bellet M, Villa F, Bernardo A, Ciruelos E, Karlsson P, Neven P, Climent M, Müller B, Jochum W, Bonnefoi H, Martino S, Davidson NE, Geyer C, Chia SK, Ingle JN, Coleman R, Solbach C, Thürlimann B, Colleoni M, Coates AS, Goldhirsch A, Fleming GF, Francis PA, Speed TP, Regan MM, Loi S. Luen SJ, et al. Among authors: macgrogan g. Ann Oncol. 2023 Apr;34(4):397-409. doi: 10.1016/j.annonc.2023.01.009. Epub 2023 Jan 25. Ann Oncol. 2023. PMID: 36709040 Free PMC article.
Cancer cells transfer invasive properties through microRNAs contained in collagen tracks.
Rouyer L, Normand L, Richard E, Allain N, Giraud J, Di-Tommaso S, Dourthe C, Raymond AA, Dupuy JW, Moreau K, Iggo R, MacGrogan G, Dugot-Senant N, Bouter A, Tan S, Favereaux A, Moreau V, Luco RF, Ros M, Saltel F. Rouyer L, et al. Among authors: macgrogan g. Cell Rep. 2025 Dec 23;44(12):116725. doi: 10.1016/j.celrep.2025.116725. Epub 2025 Dec 10. Cell Rep. 2025. PMID: 41379613 Free article.
[Apocrine lesions of the breast].
MacGrogan G. MacGrogan G. Ann Pathol. 2025 Mar 18:S0242-6498(25)00031-8. doi: 10.1016/j.annpat.2025.03.001. Online ahead of print. Ann Pathol. 2025. PMID: 40107901 French.
Machine learning-based spatial characterization of tumor-immune microenvironment in the EORTC 10994/BIG 1-00 early breast cancer trial.
Zerdes I, Matikas A, Mezheyeuski A, Manikis G, Acs B, Johansson H, Boyaci C, Boman C, Poncet C, Ignatiadis M, Bai Y, Rimm DL, Cameron D, Bonnefoi H, Bergh J, MacGrogan G, Foukakis T. Zerdes I, et al. Among authors: macgrogan g. NPJ Breast Cancer. 2025 Mar 7;11(1):23. doi: 10.1038/s41523-025-00730-1. NPJ Breast Cancer. 2025. PMID: 40055382 Free PMC article.
Darolutamide or capecitabine in triple-negative, androgen receptor-positive, advanced breast cancer (UCBG 3-06 START): a multicentre, non-comparative, randomised, phase 2 trial.
Bonnefoi H, Lerebours F, Pulido M, Arnedos M, Tredan O, Dalenc F, Guiu S, Teixeira L, Mollon D, Levy C, Verret B, Dawood H, Deiana L, Mouret Reynier MA, Augereau P, Canon JL, Huchet N, Guyonneau C, Lemonnier J, MacGrogan G, Gonçalves A, Darbo E, Iggo R. Bonnefoi H, et al. Among authors: macgrogan g. Lancet Oncol. 2025 Mar;26(3):355-366. doi: 10.1016/S1470-2045(24)00737-X. Epub 2025 Feb 17. Lancet Oncol. 2025. PMID: 39978376 Free article. Clinical Trial.
Development of Radiopharmaceuticals for NPY Receptor-5 (Y5) Nuclear Imaging in Tumors by Synthesis of Specific Agonists and Investigation of Their Binding Mode.
Bodin S, Peuker LC, Jestin E, Alves ID, Velasco V, Ait-Arsa I, Schollhammer R, Lamare F, Vimont D, MacGrogan G, Hindié E, Beck-Sickinger AG, Morgat C. Bodin S, et al. Among authors: macgrogan g. Bioconjug Chem. 2023 Nov 15;34(11):2014-2021. doi: 10.1021/acs.bioconjchem.3c00313. Epub 2023 Aug 9. Bioconjug Chem. 2023. PMID: 37556437
218 results